Corporate Social Responsibility

Our strategy is driven by our core values

Patient-centered innovation: We prioritize advancements that enhance response rates and minimize toxicity, improving both patient experience and outcomes.

Commitment to personalization: We believe in a future where treatment is as unique as each patient, focusing on tailored solutions that are both safe and effective.

Compassion and protection: Our commitment to safeguarding patients from ineffective treatments underlines our dedication to their well-being.

Excellence in combination therapy: By combining cisplatin and PD-(L)1 inhibitors, we are setting new standards for cancer treatment through innovative approaches.